1492 Capital Management LLC Collegium Pharmaceutical, Inc Transaction History

1492 Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $1.2 Million - $1.58 Million	-75,988 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $573,083 - $869,799	36,997 Added 94.89%	75,988 $1.33 Million
Q1 2020 May 12, 2020	BUY	$13.89 - $25.45 $541,584 - $992,320	38,991 New	38,991 $637,000
Q3 2019 Nov 05, 2019	SELL	$10.16 - $13.28 $1.32 Million - $1.73 Million	-130,219 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$10.62 - $16.59 $71,600 - $111,849	-6,742 Reduced 4.92%	130,219 $1.71 Million
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $179,636 - $247,628	-13,228 Reduced 8.81%	136,961 $2.07 Million
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $2.22 Million - $2.96 Million	150,189 New	150,189 $2.58 Million

236

39.4M

84.2K

18.6K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.34B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.